ADN Advent Energy: יתרת חוב לטווח ארוך של החברה

Data illustrating the price evolution of quotes on GURU.Markets serves as an indicator for Advent Technologies (ADN), which develops innovative hydrogen cells, balancing between US and European markets to minimize political risks and optimize membrane logistics. The current figure is 0.00. The business scales profits through the licensing of patented chemical compositions, allowing the company to monetize intellectual property without incurring direct assembly costs.

Long-term debt records the aggregate of credit obligations with maturities exceeding one year, excluding market volatility. This metric measures financial leverage and the stability of the capital structure. The long-term liability dynamics of Advent Technologies (ADN) reflect the costs of developing proprietary membrane technologies. Capital-intensive R&D and government support determine the volume of borrowings. Analyzing this trend allows for an assessment of debt load risk when scaling the hydrogen business.